ACA vs PRIM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

ACA

53.3
AI Score
VS
ACA Wins

PRIM

52.1
AI Score

Investment Advisor Scores

ACA

53score
Recommendation
HOLD

PRIM

52score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ACA PRIM Winner
Forward P/E 35.8423 38.3142 ACA
PEG Ratio 2.2431 1.2169 PRIM
Revenue Growth 1.7% -10.7% ACA
Earnings Growth 448.6% -60.5% ACA
Tradestie Score 53.3/100 52.1/100 ACA
Profit Margin 16.8% 1.9% ACA
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY PRIM

Relative Price Performance (Last 90 Days)

ACA 1M: -0.1% · 3M: +21.6% PRIM 1M: -14.8% · 3M: -29.8%

Current Technical Phase

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 55

RSI (14): 54.6 · Price: $144.90

PRIM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.7%), weak momentum, RSI 39

RSI (14): 39.2 · Price: $77.18

Fundamentals Snapshot

Metric ACA PRIM
Market Cap
Forward P/E 28.3 14.8
Trailing P/E 32.5 31.3
Revenue (TTM)
Revenue Growth 0.0% -0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.1% 0.0%
EPS 4.47 2.53
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.